Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection
Clinical trial NCT02637999 · COMPLETED
Trial details
- NCT number
- NCT02637999
- Sponsor
- Hepatera Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-13
- Primary completion
- 2016-01-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.